Vice-President of the Russian Academy of Sciences Vladimir Chekhonin said that ran is preparing to interact with Chinese colleagues from China on the prevention and treatment of coronavirus COVID-19. It is expected that the collaboration will address both biomedical and clinical aspects.
In particular, according to Chekhonin, Chinese experts were interested in the possibility of using previously created in the Institute of organic synthesis named RAS Ural branch of RAS antiviral drug.
